EXEL
Exelixis, Inc. · Healthcare
EVP and General Counsel Jeffrey Hessekiel sold $1.7M of Exelixis, Inc.
Sold$1,706,500
$34.13Price
50,000Shares
−9%Stake
What EXEL did after the filing
- The stock from Tue, Nov 5 close, $34.77
- −3.2%
- S&P 500, same days
- +1.7%
Measured over 30 trading days, to the Dec 18 close.
Traded Fri, Nov 1. Filed Tue, Nov 5, 2:05 PM ET, during the session. Returns use the Nov 5 close and the Dec 18 close. Not investment advice.